Telenursing to improve oral health in people with COPD
The Effect of Telenursing Interventions on Oral Health in Individuals With COPD
This project will try telenursing education via video calls plus daily reminders to see if they help people with COPD improve their oral health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 40 Years and up |
| Sex | All |
| Sponsor | Çanakkale Onsekiz Mart University Academic / other |
| Locations | 1 site (Çanakkale) |
| Trial ID | NCT07462221 on ClinicalTrials.gov |
What this trial studies
This is a pre-test/post-test controlled experiment comparing a telenursing intervention to usual care for adults with COPD. The intervention group receives oral health education by video call within 24 hours of the pre-test and daily oral health reminders, while the control group receives no education. Oral health and oral health–related quality of life are measured at baseline and again one month later. The trial is conducted with inpatient participants at a single university hospital who have internet access and a smartphone or tablet.
Who should consider this trial
Good fit: Ideal candidates are people aged 40 or older with a COPD diagnosis for at least six months who are hospitalized in internal medicine or surgical units, have no communication barriers, and have internet access plus an Android/iOS device they can use.
Not a fit: Patients without internet or a compatible mobile device, those under 40, newly diagnosed (<6 months), in intensive care, or with communication barriers are unlikely to benefit or participate.
Why it matters
Potential benefit: If successful, the intervention could improve oral hygiene and related quality of life for people with COPD and reduce oral-health–related complications.
How similar studies have performed: Telehealth and tele-nursing approaches have shown benefits for COPD self-management and adherence in prior studies, but telenursing specifically focused on oral health in COPD is limited and relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must have been diagnosed with COPD for at least 6 months, * receive inpatient treatment in internal medicine and surgical clinics, * signed the informed consent form to participate in the study, * have internet access and a mobile device with Android/iOS operating system, * be able to use a phone, * ≥ 40 years old, * have no communication barriers, * mild (Stage 1), moderate (Stage 2), severe (Stage 3), or very severe (Stage 4) stages according to the GOLD (2023) report. Exclusion Criteria: * Those diagnosed with COPD less than 6 months ago, * Those receiving outpatient treatment, * Those hospitalized in the intensive care unit, * Those without internet access and a mobile device with Android/iOS operating system, * Those who do not have the ability to use a phone, * Those under 40 years of age, * Those with communication barriers, * Those who wish to withdraw from the research/withdraw from participation during the research process,
Where this trial is running
Çanakkale
- Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University — Çanakkale, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: SEVDA ATEŞ, Associate Professor — Çanakkale Onsekiz Mart University
- Study coordinator: SEVDA ATEŞ, Associate Professor
- Email: sevdaefil@comu.edu.tr
- Phone: 0905536088072
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.